![]() The Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) research team were the first to demonstrate how this TBI blood test can be used for the benefit of TBI patients in clinical care. It was originally developed in collaboration with the US Department of Defense (DOD), which have played a role in increasing detection and evaluation of TBI. READ MORE: Biogen, Apple to Initiate Study to Develop Cognitive Health Digital BiomarkersĪbbott noted that the plasma test provides results with 95.8% sensitivity and 99% negative predictive value. A positive test result can complement CT scans and help clinicians evaluate whether a patient has TBI. The cartridge is then inserted into the handheld instrument. 1 “You can’t treat what you don’t know and now physicians will be equipped with critical, objective information that will help them provide the best care possible, allowing patients to take steps to recover, prevent reinjury, and get back to doing the things they care about the most.”įollowing a blood sample drawn from a patient’s arm, plasma is extracted with a centrifuge and applied to the test’s cartridge. "Healthcare providers have been waiting for a blood test for the brain and now we have 1,” Beth McQuinston, MD, medical director, Abbott’s diagnostic business, said in a statement. Computed tomography (CT) scans, often used to diagnose concussion, can then be ruled out if a patient has a negative test result. ![]() ![]() The test measures specific proteins present in the blood after a TBI and provides results in as little as 15 minutes after plasma is placed in the test cartridge. The FDA has given 510 (k) clearance for the first rapid handheld traumatic brain injury (TBI) blood test, which will help clinicians assess patients with suspected mild TBIs, including concussions, and will be ran on Abbott’s handheld i-STAT Alinity platform. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |